Parenteral artemisinins are associated with reduced mortality and neurologic deficits and improved long-term behavioral outcomes in children with severe malaria

BACKGROUND: In 2011, the World Health Organization recommended injectable artesunate as the first-line therapy for severe malaria (SM) due to its superiority in reducing mortality compared to quinine. There are limited data on long-term clinical and neurobehavioral outcomes after artemisinin use for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Med
Main Authors: Conroy, Andrea L., Opoka, Robert O., Bangirana, Paul, Namazzi, Ruth, Okullo, Allen E., Georgieff, Michael K., Cusick, Sarah, Idro, Richard, Ssenkusu, John M., John, Chandy C.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8317420/
https://ncbi.nlm.nih.gov/pubmed/34315456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-021-02033-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados